AI-Ready Bio-Data Standards Act

The AI-Ready Bio-Data Standards Act would direct the National Institute of Standards and Technology (NIST) to establish definitions, standards, and frameworks for biological data that can be effectively used in artificial intelligence systems. Currently, biological data in the United States is fragmented and inconsistently formatted across universities, companies, and federal laboratories, which slows down research and makes it difficult for AI systems to work with the data. This bill would require NIST to create formal standards and best practices for structuring biological datasets, set requirements for federally funded research projects to generate AI-ready data, and coordinate data policies across federal agencies to ensure consistency.

If enacted, the legislation could accelerate drug discovery and medical breakthroughs by enabling researchers to spend less time cleaning and organizing data and more time generating new insights. It would also facilitate data sharing across institutions and companies, potentially leading to improved AI models for disease research and treatment. The bill reflects bipartisan concern that without coordinated standards, the United States could fall behind international competitors in AI-enabled biotechnology. The bill is currently in the Senate Commerce, Science, and Transportation Committee and has not yet been voted on by the full Senate.